Celecoxib topical - Promius Pharma

Drug Profile

Celecoxib topical - Promius Pharma

Alternative Names: DFD-07

Latest Information Update: 28 Apr 2017

Price : $50

At a glance

  • Originator Promius Pharma
  • Class Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Actinic keratosis

Most Recent Events

  • 14 Feb 2017 Phase-II/III clinical trials in Actinic keratosis (In adults) in USA (Topical) (NCT03116698)
  • 01 Aug 2016 Promius Pharma completes a phase II trial in Actinic keratosis (In the elderly, In adults) in Germany (Topical) (EudraCT2015-003804-21)
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top